Given the evolving molecular discoveries in ameloblastoma, this work presented a systematic review and meta-analysis to pool the mutation prevalence of BRAF V600E and to seek any association between BRAF V600E mutation and demographic profiles (age and sex) as well as clinicopathological features (site, histological variants, and recurrence) in ameloblastoma. Here, BRAF is linked to ameloblastoma.